Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Medassets Inc Issues FY 2013 Guidance In Line With Analysts' Estimates


Wednesday, 20 Feb 2013 04:03pm EST 

MedAssets, Inc. announced that for fiscal 2013, it expects total net revenue of between $670-$684 million, non-GAAP adjusted EBITDA of between $215-$225 million, GAAP diluted EPS $0.33-$0.43 and diluted non-GAAP adjusted EPS of $1.22-$1.32. According to I/B/E/S Estimates analysts are expecting the Company to report revenue of $678 million, EBITDA of $223 million and EPS of $1.29 for fiscal 2013. 

Company Quote

19.85
-0.11 -0.55%
26 Dec 2014